Cargando…

(tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)

The title compound, [Zr(C(5)H(5))(2)(C(4)H(9)N)(C(5)H(5)N)], was obtained from the reaction of (C(5)H(5))(2)Zr(py)(η(2)-Me(3)SiC(2)SiMe(3)) (py is pyridine) and (t)BuN=C=N(t)Bu alongside the formation of (C(5)H(5))(2)Zr(CN(t)Bu)(η(2)-Me(3)SiC(2)SiMe(3)). The zirconium atom is coordinated in a distor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaleta, Katharina, Arndt, Perdita, Spannenberg, Anke, Rosenthal, Uwe
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007953/
https://www.ncbi.nlm.nih.gov/pubmed/21588566
http://dx.doi.org/10.1107/S1600536810033556
_version_ 1782194467087843328
author Kaleta, Katharina
Arndt, Perdita
Spannenberg, Anke
Rosenthal, Uwe
author_facet Kaleta, Katharina
Arndt, Perdita
Spannenberg, Anke
Rosenthal, Uwe
author_sort Kaleta, Katharina
collection PubMed
description The title compound, [Zr(C(5)H(5))(2)(C(4)H(9)N)(C(5)H(5)N)], was obtained from the reaction of (C(5)H(5))(2)Zr(py)(η(2)-Me(3)SiC(2)SiMe(3)) (py is pyridine) and (t)BuN=C=N(t)Bu alongside the formation of (C(5)H(5))(2)Zr(CN(t)Bu)(η(2)-Me(3)SiC(2)SiMe(3)). The zirconium atom is coordinated in a distorted tetra­hedral geometry by two cyclo­penta­dienyl ligands, a pyridine ligand, and a tert-butyl­imido ligand via a Zr=N double bond. The tert-butyl group is disordered over two positions in a 0.634 (5):0.366 (5) ratio.
format Text
id pubmed-3007953
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-30079532010-12-30 (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV) Kaleta, Katharina Arndt, Perdita Spannenberg, Anke Rosenthal, Uwe Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The title compound, [Zr(C(5)H(5))(2)(C(4)H(9)N)(C(5)H(5)N)], was obtained from the reaction of (C(5)H(5))(2)Zr(py)(η(2)-Me(3)SiC(2)SiMe(3)) (py is pyridine) and (t)BuN=C=N(t)Bu alongside the formation of (C(5)H(5))(2)Zr(CN(t)Bu)(η(2)-Me(3)SiC(2)SiMe(3)). The zirconium atom is coordinated in a distorted tetra­hedral geometry by two cyclo­penta­dienyl ligands, a pyridine ligand, and a tert-butyl­imido ligand via a Zr=N double bond. The tert-butyl group is disordered over two positions in a 0.634 (5):0.366 (5) ratio. International Union of Crystallography 2010-08-28 /pmc/articles/PMC3007953/ /pubmed/21588566 http://dx.doi.org/10.1107/S1600536810033556 Text en © Kaleta et al. 2010 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Kaleta, Katharina
Arndt, Perdita
Spannenberg, Anke
Rosenthal, Uwe
(tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title_full (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title_fullStr (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title_full_unstemmed (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title_short (tert-Butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(IV)
title_sort (tert-butyl­imido)bis­(η(5)-cyclo­penta­dien­yl)pyridine­zirconium(iv)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007953/
https://www.ncbi.nlm.nih.gov/pubmed/21588566
http://dx.doi.org/10.1107/S1600536810033556
work_keys_str_mv AT kaletakatharina tertbutylimidobisē5cyclopentadienylpyridinezirconiumiv
AT arndtperdita tertbutylimidobisē5cyclopentadienylpyridinezirconiumiv
AT spannenberganke tertbutylimidobisē5cyclopentadienylpyridinezirconiumiv
AT rosenthaluwe tertbutylimidobisē5cyclopentadienylpyridinezirconiumiv